BIMI International Medical Inc.
BIMI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.03 | 0.01 |
| FCF Yield | -3,128.54% | -152.86% | -211.89% | -79.23% |
| EV / EBITDA | -0.19 | -0.17 | -2.08 | -2.11 |
| Quality | ||||
| ROIC | -118.77% | -35.54% | -19.64% | -11.44% |
| Gross Margin | 16.48% | 11.38% | 19.02% | -92.42% |
| Cash Conversion Ratio | 0.46 | 0.04 | 0.93 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.71% | 412.94% | 25.22% | -73.52% |
| Free Cash Flow Growth | -390.58% | 44.65% | -82.91% | -500.28% |
| Safety | ||||
| Net Debt / EBITDA | -0.17 | -0.12 | -1.53 | -0.06 |
| Interest Coverage | -4.47 | -3.32 | -44.89 | -155.35 |
| Efficiency | ||||
| Inventory Turnover | 1.29 | 3.67 | 14.15 | 0.43 |
| Cash Conversion Cycle | 13.14 | 102.93 | 57.43 | 872.49 |